Related Experiment Video

Updated: Jun 9, 2026

Adaptation of Semiautomated Circulating Tumor Cell (CTC) Assays for Clinical and Preclinical Research Applications
14:14

Adaptation of Semiautomated Circulating Tumor Cell (CTC) Assays for Clinical and Preclinical Research Applications

Published on: February 28, 2014

PET/CT in cancer research: from preclinical to clinical applications

S Del Vecchio1, A Zannetti, R Fonti

  • 1Department of Biomorphological and Functional Sciences, University of Naples Federico II, Naples, Italy. delvecc@unina.it

Contrast Media & Molecular Imaging
|September 3, 2010
PubMed

Insights

Advanced imaging techniques like PET/CT enable the visualization of molecular targets in cancer. This allows for noninvasive detection and monitoring of tumor aggressiveness and treatment response.

Area of Science:

  • Oncology
  • Molecular Imaging
  • Biochemistry

Background:

  • Genetic and biochemical insights into tumor growth have revealed novel targets for cancer management.
  • Advancements in hybrid imaging systems facilitate the visualization of molecular and physiological tumor abnormalities.

Purpose of the Study:

  • To highlight the application of Positron Emission Tomography/Computed Tomography (PET/CT) in visualizing biological processes and target expression in cancer.
  • To demonstrate the noninvasive detection and monitoring of tumor aggressiveness, invasiveness, and treatment resistance using PET/CT.

Main Methods:

  • Utilizing PET/CT with radiolabeled molecular probes for in vivo evaluation of complex biological processes.
  • Applying these techniques in both animal tumor models and human cancer patients.

Main Results:

  • PET/CT enables visualization of key cancer processes including proliferation, apoptosis, angiogenesis, and metastasis.
  • Demonstrated feasibility of assessing gene expression, receptor-ligand interactions, nutrient metabolism, and substrate transport in tumors.
  • Provided examples of noninvasive detection of tumor aggressiveness markers and evaluation of therapeutic response.

Conclusions:

  • PET/CT imaging with molecular probes is a powerful tool for noninvasive cancer detection, characterization, and treatment monitoring.
  • This technology aids in identifying markers of tumor aggressiveness and evaluating treatment efficacy in preclinical and clinical settings.

More Related Videos

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer06:51

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer

Published on: July 21, 2018

Preclinical Positron Emission Tomography with Body Conforming Animal Molds for Cloud-Based Automated Image Analysis in Mice07:45

Preclinical Positron Emission Tomography with Body Conforming Animal Molds for Cloud-Based Automated Image Analysis in Mice

Published on: October 25, 2024

Related Concept Videos

Mouse Models of Cancer Study02:43

Mouse Models of Cancer Study

Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
Mouse Models of Cancer Study02:43

Mouse Models of Cancer Study

Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...